"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Descriptor ID |
D009367
|
MeSH Number(s) |
E01.789.625
|
Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1997 | 0 | 6 | 6 |
1998 | 0 | 4 | 4 |
1999 | 0 | 3 | 3 |
2000 | 1 | 4 | 5 |
2001 | 2 | 8 | 10 |
2002 | 0 | 8 | 8 |
2003 | 0 | 7 | 7 |
2004 | 0 | 10 | 10 |
2005 | 2 | 10 | 12 |
2006 | 0 | 11 | 11 |
2007 | 0 | 16 | 16 |
2008 | 1 | 20 | 21 |
2009 | 4 | 16 | 20 |
2010 | 0 | 18 | 18 |
2011 | 0 | 22 | 22 |
2012 | 0 | 14 | 14 |
2013 | 1 | 21 | 22 |
2014 | 0 | 24 | 24 |
2015 | 0 | 15 | 15 |
2016 | 2 | 23 | 25 |
2017 | 0 | 20 | 20 |
2018 | 0 | 13 | 13 |
2019 | 2 | 9 | 11 |
2020 | 1 | 12 | 13 |
2021 | 0 | 16 | 16 |
2022 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Neoadjuvant QUAD shot for downstaging or temporizing locally advanced oral cavity cancer prior to definitive surgery. Oral Oncol. 2022 10; 133:106029.
-
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (=10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer. Gynecol Oncol. 2022 09; 166(3):410-416.
-
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecol Oncol. 2022 04; 165(1):82-89.
-
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022 01 31; 12(1):1659.
-
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2022 02; 164(2):398-405.
-
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors. HPB (Oxford). 2022 05; 24(5):681-690.
-
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer. Eur J Cancer. 2021 11; 157:415-423.
-
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II. J Clin Oncol. 2021 11 10; 39(32):3623-3632.
-
Merkel cell carcinoma: treatment and outcomes over a 10-year period at a high-volume academic center. Int J Dermatol. 2022 May; 61(5):558-563.
-
New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []. Cancer Lett. 2021 10 10; 518:207-213.